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Abstract
Introduction
Concerns about risk compensation—increased risk behaviours in response to a perception
of reduced HIV transmission risk—after the initiation of ART have largely been dispelled in
empirical studies, but other changes in sexual networking patterns may still modify the
effects of ART on HIV incidence.
Methods
We developed an exploratory mathematical model of HIV transmission that incorporates
the possibility of ART clusters, i.e. subsets of the sexual network in which the density of
ART patients is much higher than in the rest of the network. Such clusters may emerge as a
result of ART homophily—a tendency for ART patients to preferentially form and maintain
relationships with other ART patients. We assessed whether ART clusters may affect the
impact of ART on HIV incidence, and how the influence of this effect-modifying variable
depends on contextual variables such as HIV prevalence, HIV serosorting, coverage of HIV
testing and ART, and adherence to ART.
Results
ART homophily can modify the impact of ART on HIV incidence in both directions. In con-
centrated epidemics and generalized epidemics with moderate HIV prevalence ( 10%),
ART clusters can enhance the impact of ART on HIV incidence, especially when adherence
to ART is poor. In hyperendemic settings ( 35% HIV prevalence), ART clusters can
reduce the impact of ART on HIV incidence when adherence to ART is high but few people
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living with HIV (PLWH) have been diagnosed. In all contexts, the effects of ART clusters on
HIV epidemic dynamics are distinct from those of HIV serosorting.
Conclusions
Depending on the programmatic and epidemiological context, ART clusters may enhance
or reduce the impact of ART on HIV incidence, in contrast to serosorting, which always
leads to a lower impact of ART on HIV incidence. ART homophily and the emergence of
ART clusters should be measured empirically and incorporated into more refined models
used to plan and evaluate ART programmes.
Introduction
Early initiation of antiretroviral therapy (ART) significantly improves the survival of persons
living with HIV (PLWH) and may reduce HIV transmission to uninfected partners by more
than 90% [1–3]. Somemathematical models suggest that treatment-as-prevention (TasP) pro-
grammes could lead to HIV elimination, even in some of the most severely affected settings [4,
5]. International organizations including PEPFAR, the International AIDS Society, UNAIDS,
The Global Fund to Fight AIDS, Tuberculosis, and Malaria, and the International Association
of Providers of AIDS Care have thus placed ART scale-up at the centre of their approach to
achieving an “AIDS-free generation” [6–8].
But the clinical efficacy of ART in preventing HIV transmission may not translate into an
equally large population-level impact on HIV incidence in real-life settings [9]. In particular,
for TasP programmes to be effective, a high proportion of PLWH must 1) be diagnosed, 2) be
linked to care, 3) remain in care, and 4) adhere to ART. An ambitious programme of imple-
mentation science now seeks to improve each step of this HIV treatment cascade [10–17].
The effects of ART on HIV incidencemay also depend on changes in sexual networking
dynamics during the course of ART scale-up. The Health BeliefModel [18] suggests that “risk
compensation” is one mechanism through which negative feedback loops betweenART and
HIV incidencemay emerge (Fig 1). Risk compensation occurs when people increase their indi-
vidual risk behaviours (e.g. having more sexual partners) in response to the increased availabil-
ity of interventions to prevent and manage HIV infection [19–23]. Empirical studies of risk
compensation have however generally concluded that there was limited risk compensation
after ART initiation. Neither ART patients, nor HIV-negative individuals living in communi-
ties where ART becomes available, seem to increase the number of their sexual partners, for
example [24–26].
ART homophily in sexual networks
Even if ART does not lead to risk compensation, other feedback loops may emerge in the com-
plex causal system linking ART scale-up and HIV incidence. In particular, increasing ART
availability may affect the process of partnership selection/dissolution through which sexual
networks are formed (Fig 1). For example, during the course of ART scale-up, ART patients
may increasingly seek to form new relationships with other ART patients. Similarly, relation-
ships between two ART patients may be less likely to dissolve than other relationships in which
only one of the two partners is an ART patient. We call this phenomenon “ART homophily”.
ART Clusters in Sexual Networks Can Modify the Impact of ART on HIV Incidence
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Qualitative studies have documented several psychosocialmechanisms that may lead to such
relationship dynamics. For an ART patient, ART homophily may indeed reduce fear for further
HIV transmission [27] and ease anxiety about HIV status disclosure [28]. ART homophily also
gives patients direct access to emotional support [29] and facilitates sharing of coping strategies
during episodes of drug- induced side effects or HIV treatment fatigue [30]. In addition, ART
patients may share common life histories, e.g., being widowed or having lost a previous partner.
Finally, in a number of ART programmes, ART patients frequently interact with each other dur-
ing dedicated ART clinics, in support groups or in various income-generating activities [31].
This increased social proximity may lead to emotional closeness, and may provide additional
opportunities to form new sexual partnerships with others who are also ART patients.
ART homophily has not been considered in existing investigations of sexual networking
during the course of ART scale-up. Instead, most mathematical models of TasP have consid-
ered that sexual networks were formed either at random, or by mixing between different pre-
defined risk groups (e.g., [5, 32–34]). Empirical investigations of sexual networks have mainly
focused on preferences for partners of the same age, gender, educational level or ethnic group
[35–43]. In the subpopulation of men who have sex with men, another form of homophily
called “serosorting” has also been extensively investigated [44–53]. This is a behavioural strat-
egy in which individuals preferentially select partners of the same HIV serostatus as them, so
as to limit HIV transmission risks while possibly enabling unprotected sex.
The emergence of ART clusters in sexual networks
Despite this lack of attention, ART homophily has the potential to profoundly modify the
structure of sexual networks, and as a result the level of exposure to HIV among HIV-negative
Fig 1. Causal pathways linking the availability of ART to HIV incidence within a population. Notes: wide arrows represent direct pathways,
whereas solid narrow arrows represent feedback loops that have been considered in the literature on treatment-as-prevention. The dotted arrow
represents ART homophily, another causal feedback loop that has not been considered in the literature on treatment-as-prevention.
doi:10.1371/journal.pone.0163159.g001
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individuals in the population. In the absence of ART homophily (Fig 2A), ART patients are
likely disseminated throughout the sexual network and may come into contact with both
untreated PLWH and HIV-negative individuals. In the presence of ART homophily however,
ART patients may form “ART clusters”, which are subsets of the sexual network in which the
density of ART patients is much higher than in the rest of the network. In the extreme case
where ART patients only form relationships with other ART patients, these clusters may
become disconnected from the rest of the network (Fig 2B). As ART clusters emerge, the extent
of sexual contact betweenART patients and other population members declines. At the same
time, the number of relations between untreated (and thus likely more infectious) PLWH and
HIV-negative individuals may increase to offset the reduced availability of ART patients to
form new relationships with members of the other population groups (Fig 2B). If the level of
exposure to HIV changes in a population during the course of ART scale-up as a result of ART
homophily, then the impact of ART on HIV incidencemay be modified.
ART clusters should not be confusedwith HIV transmission clusters. The latter typically
refer to PLWH who share similar HIV genome sequences, as a result of being closely related in
the HIV transmission network. ART clusters, on the other hand, may include relationships
between PLWH who are very far removed from one another in the transmission network.
Hence, ART clusters may connect PLWH whose HIV genome sequences are highly dissimilar.
We constructed an exploratory mathematical model of the impact of ART on HIV inci-
dence that includes the possibility of ART homophily. This is not a formal network model, nor
does it aim to describe the long-term dynamics of an epidemic. Instead, we solely used this
model to assess whether the emergence of ART homophily in sexual networks may affect the
effectiveness of ART in preventing HIV infections.
Methods
Model structure
We developed a static mathematical model for the population-level impact of ART on HIV
incidence. The model population contains four interacting subgroups: HIV-negative individu-
als, PLWH who are unaware of their infection (and thus are not treated and remain infective),
PLWH who are aware of their infection but are not treated (and thus remain infective), and
PLWH who are on ART (“ART patients”). The latter group becomes less infective but the sup-
pressive effect of ART on infectivity depends on their level of adherence to ART (see below).
Fig 2. Illustration of the effects of ART homophily on HIV exposure in a population. HIV-negative individuals appear in empty circles,
while people living with HIV (PLWH) are represented by triangles. ART patients appear in blue triangles, whereas other (untreated) PLWH
appear in red triangles. In panel A) the network is formed at random, in panel B) the network is formed based on ART homophily: all HIV-
negative individuals are connected only to the one PLWH not on ART, and the 3 ART patients are connected together in an ART cluster.
doi:10.1371/journal.pone.0163159.g002
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Model parameters include the population prevalence of HIV (noted h), the fraction of
PLWH who know that they are HIV-positive (d), the uptake of ART among diagnosed PLWH
(a) and the reduction in HIV transmission associated with ART in serodiscordant couples (r).
The coverage of ART, i.e. the proportion of PLWH who are on ART is defined as da. We define
r as the HIV incidence in serodiscordant couples in which the infected partner has initiated
ART divided by the HIV incidence among serodiscordant couples in which the infected part-
ner has not initiated ART. It is thus an incidence rate ratio: the lower the value of r, the larger
the reduction in HIV incidence associated with ART in serodiscordant couples. The value of r
depends primarily on the extent to which the infected partner in the couple adheres to ART.
The model also accounts for the average number of partners per time unit (p), the average
number of unprotected sex acts per partnership (s), and the average HIV transmission proba-
bility per unprotected sex act (i).
The key parameters describing sexual networking patterns in this interacting population are
n, the degree of serosorting andm, the degree of ART homophily. Both parameters vary between
0 and 1. When n =m = 0, relationships in the population are formed at random with respect
to HIV status and ART status. This means that relationships between different population sub-
groups are formed proportionately to the prevalence of each of these subgroups in the popula-
tion.When n = 1 andm = 0, diagnosedPLWH exclusively form partnerships with other
diagnosedPLWH, but among those, PLWH on ART do not preferentially seek partners who are
also on ART. Instead, partnerships between PLWH who are on and off ART are formed propor-
tionately to the relative size of these groups. Whenm = 1, ART patients exclusively form part-
nerships with other ART patients, resulting in the emergence of ART clusters that are separated
from the rest of the sexual network, as in Fig 2B.When 0< n< 1, diagnosedPLWH have pref-
erences for being in relationships with other diagnosedPLWH, but still have a proportion of
their relationships with other PLWH who are not yet aware of their status and with HIV-nega-
tive people. Likewise,when 0<m< 1, ART patients have preferences for being in relationships
with other ART patients, but still have a proportion of their relationships with others who are
not ART patients.
Assumptions
To simplify the analysis, we assumed that there are no differences in infectivity between PLWH
who are aware or unaware of their HIV-positive status if they are not treated. Similarly, the
infectivity of ART patients depends solely on their level of adherence to ART. We further
assumed no risk compensation: ART initiation does not lead to changes in the number of sex-
ual partners individuals have, nor does it affect condom use or other determinants of the HIV
transmission process within couples. Finally, we assumed homogeneity in sexual activity: every
member of the population has the same number of partners and each sexual partnership entails
the same number of sex acts.
Model equations
In serodiscordant couples, when the HIV-positive partner is not on ART, the per-partnership
probability of HIV transmission, noted t, is 1 − (1 − i)s. When the HIV-positive partner is on
ART, this probability, noted tART, is reduced because of the factor r. It is then equal to 1 − (1 − i)rs.
The rates at whichHIV-negative people form relationships with diagnosedPLWH on and off
ART are phda(m − 1)(n − 1) and phd(1 − a)(1 − n) respectively. The rates of relationship forma-
tion with other HIV-negatives and undiagnosedPLWH are proportional to the size of the popula-
tions of HIV-negatives and undiagnosedPLWH: 1 − h and h(1 − d), respectively. Taken together,
these four rates sum to p, the annual number of partners that individuals have in our model. The
ART Clusters in Sexual Networks Can Modify the Impact of ART on HIV Incidence
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HIV incidence rate, I, can then be calculated from these partner turnover rates and their associated
per-partnership probabilities of HIV transmission (S1 File). Lastly, the population-level impact of
ART on HIV incidence, I/InoART − 1, is defined as the relative change in the HIV incidence rate,
associatedwith ART. In this formulation, InoART is calculated as I except that none of the PLWH
are on ART (a = 0).
Values of model parameters: We considered three HIV prevalence levels (1%, 10% and
35%). The case where h = 1% represents situations typical of concentrated epidemics, whereas
h = 35% represents situations common in certain demographic strata of hyperendemic settings
[54–57]. Percentages of PLWH that are aware of their HIV status (d) and ART uptake among
these diagnosed PLWH (a) ranged from 50% to 90% [58, 59], under the assumption of imme-
diate, unconditional access to ART, as currently being piloted in TasP trials [60–63]. The
upper bounds for the ranges of a and d in our model are also consistent with the new 90-90-90
UNAIDS targets for ART scale-up. The range of values for (r), i.e. the reduction in HIV inci-
dence in serodiscordant couples associated with ART, was derived from a recent systematic
review of prospective studies of the effect of ART on HIV transmission [9]. In contexts of high
adherence to ART, the incidence of HIV in serodiscordant couples in which the PLWH is on
ART, is reduced by 96% (i.e. r = 0.04) compared to similar couples in which the PLWH has not
initiated ART. In contexts of low adherence to ART, the incidence of HIV in such serodiscor-
dant couples is only reduced by 66% (i.e. r = 0.34). There are currently no quantitative data on
the extent of serosorting in generalized epidemics in heterosexual networks, or on the level of
ART homophily in sexual networks.We thus analyzed situations in which the parameters n
andm vary between 0 (no homophily) and 1 (perfect homophily).
Model analysis
Our goal in this exploratory model is to assess whether the addition of a parameter describing a
previously understudied sexual networking pattern (i.e., ART homophily) might modify the
impact of ART on HIV incidence.We thus do not seek to characterise the dynamics and steady
state properties of the HIV transmission system described above.
We began by conducting a one-way analysis to assess how each model parameter relates to
the population-level impact of ART under the assumption of randommixing with respect to
ART status (m = 0). We then explored how the presence of ART homophily modifies the
impact of ART on HIV incidence. To do so, we computed the impact of ART on HIV incidence
(I/InoART − 1) under 2 scenarios: a baseline scenario without any ART-homophily (m = 0) and
a test scenario with perfect ART homophily (m = 1). The ratio of these two estimates of ART
impact is the modification factor associated with ART homophily. When it is above 1, ART
homophily enhances the impact of ART on HIV incidence, compared to a situation in which
ART patients select partners at random.When this modification factor is below 1, then ART
homophily reduces the impact of ART on HIV incidence.We conducted another one-way
analysis to assess how each model parameter listed in Table 1 affects this modification factor.
Finally, we conducted a multi-way analysis to identify the epidemiological and program-
matic conditions under which ART homophily may enhance or reduce the impact of ART on
HIV incidence. Specifically, we calculated the modification factor associated with ART homo-
phily for each combination (h; d; a; r; n) of HIV prevalence (h), HIV diagnosis (d), ART uptake
(a) intra-couple effectiveness of ART (r), and serosorting (n) defined in Table 1. Since the
parameters d and r are allowed to vary over a range of values, the results from the multi-way
analysis are presented as contour plots.
To facilitate further exploration of the behaviour of the model and strengthen intuition for the
model results, we developed an online app (https://artclustering.shinyapps.io/ModelExploration)
ART Clusters in Sexual Networks Can Modify the Impact of ART on HIV Incidence
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that interactively illustrates how the sexual network that connects the four population subgroups,
and the impact of ART on HIV incidence, change as a function of ART-homophily and the other
model parameters.
Results
ART impact in the absence of ART homophily
In sexual networks without ART-homophily (m = 0), in our model, the impact of ART on HIV
incidence only depends on the proportion of PLWH aware of their status (d), ART uptake (a)
the intra-couple ART effectiveness (r), and the extent of serosorting among PLWH (n). The
annual number of partners (p), the average number of unprotected sex acts per relationship (s)
and the per sex act probability of HIV transmission (i) do not affect the impact of ART on HIV
incidence in this model (Fig 3). This does not mean that these parameters do not influence
HIV incidence. Indeed, HIV incidence increases with increasing values of p, s and i, but the rel-
ative change in HIV incidence when comparing scenarios with and without ART is unaffected.
Henceforth, these parameters were not included in the multi-way analysis (Table 1). Serosort-
ing among PLWH reduces the impact of ART on HIV incidence. In particular, when n = 1, all
the partnerships formed betweenHIV-negative people and PLWH are necessarily with undiag-
nosed PLWH. In this context, the impact of ART drops to zero.
Modification factor associated with ART homophily
Fig 4 indicates that the modification factor associated withm, i.e. the relative change in the
impact of ART that results from the presence of ART homophily, depends on HIV prevalence
(h), the fraction of PLWH aware of their status (d), and adherence to ART (r), but not on other
model parameters. In particular, the modification factor appears largest in settings where
adherence to ART is low. Changes in the prevalence of serosorting among PLWH, on the other
hand, have no effects on the modification factor associated with ART homophily.
Analysis of the model’s equations (S1 File) suggests that ART clusters will weaken the pre-
vention benefits of ART if the subpopulation of undiagnosedPLWH is larger than r times
the combined size of the subpopulations of HIV-negative people and undiagnosedPLWH.
Table 1. Range of parameters values explored in mathematical model.
Parameter Description Range in one-way analysis Values used in multi-way analysis
h HIV prevalence 1%– 35% (10%) 1%, 10% and 35%
d Proportion of PLWH who are diagnosed 25%– 90% 25%– 90%
a ART uptake among diagnosed PLWH 25%– 90% 50%
p Annual number of partners 0.05–100 0.5
s Number of unprotected sex acts per relationship 1–500 200
i Per sex act HIV transmission probability 0.001–0.01 0.005
r Incidence rate ratio associated with ART in serodiscordant couples1 0.04–0.34 0.04–0.34
m ART assortativity index2 0–1 0; 1
n HIV serosorting index3 0–1 0; 0.5
Notes:
1 Lower values of r are associated with higher adherence to ART among PLWH in serodiscordant couples. Lower values of r are thus also associated with
larger reductions in HIV incidence in serodiscordant couples.
2 the ART assortativity measures the proportions of relationships of ART patients that are with other ART patients.
3 The HIV serosorting index measures the proportion of relationships of PLWH (regardless of diagnosis or treatment status) that are with other PLWH.
doi:10.1371/journal.pone.0163159.t001
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Fig 3. Population-level impact of ART on HIV incidence, as a function of the model parameters (one-way analysis). Notes: The impact of
ART on HIV incidence is defined as the relative change in the HIV incidence rate, associated with ART (I/InoART 1). An ART impact of 0 thus indicates
no effects of ART on HIV incidence, whereas an ART impact of -1 indicates that ART eliminates HIV incidence.
doi:10.1371/journal.pone.0163159.g003
Fig 4. Effects of model parameters on the modification factor of the impact of ART associated with ART homophily. Notes: The modification
factor is calculated by dividing the estimated impact of ART in a context with perfect ART homophily (m = 1) by the estimated impact of ART in a
context without any ART homophily (m = 0).
doi:10.1371/journal.pone.0163159.g004
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Conversely, ART clusters will augment the impact of ART on HIV incidence if the opposite is
the case. The strongest synergistic effect of ART homophily on the impact of ART on HIV inci-
dence is thus achieved when r is very large, h is small and d is large, i.e. low ART adherence in a
population with low HIV prevalence but a high fraction of PLWH being diagnosed.On the
other hand, ART homophily can reduce the prevention benefits of ART if it occurs in a context
of high HIV prevalence where not many PLWH are diagnosed (small d), but treatment effec-
tiveness is excellent (small r).
In populations with HIV prevalence 1% (Fig 5), ART homophily thus increases the
impact of ART on HIV incidence relative to a baseline without ART-homophily for virtually
all combinations of model parameters. ART homophily particularly improves the impact of
ART on HIV incidence, however, if ART patients do not strictly adhere to treatment. For
example, in settings with low ART adherence among ART patients (r = 0.34), ART homophily
Fig 5. The effect of ART homophily and serosorting on the population-level impact of ART on HIV incidence, by levels of HIV
prevalence (h), fraction of PLWH who are aware of their HIV status (d) and intra-couple effectiveness of ART (r). Contour lines
indicate the impact of ART on HIV incidence in the absence of ART clusters (m = 0). Color-coding indicates the modification factor of ART
clusters: the factor by which the ART impact on HIV incidence increases (> 1 in blue) or decreases (< 1 in red) when comparing the case
of m = 1 to the case of m = 0. For example, in the darkest blue areas, the impact of ART on HIV incidence is 50% greater in the presence of
perfect ART homophily (m = 1) than it would have been if networks were formed without any ART homophily (m = 0). The uptake of ART
among diagnosed PLWH (a) was fixed at 50% in all model scenarios shown.
doi:10.1371/journal.pone.0163159.g005
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increases the impact of ART on HIV incidence by close to 50%, regardless of other model
parameters. On the other hand, if adherence is high (r = 0.04), then ART homophily only
increases the impact of ART by 10% relative to a situation in which networks are formed at
random.
Similar results are obtained in populations with HIV prevalence 10%, but the potential
effects of ART homophily on the population-level impact of ART varymore widely when HIV
prevalence 35% (Table 2). In such hyper-endemic populations, ART homophily may also
improve the impact of ART on HIV incidence when adherence to ART is low. For example, in
contexts with high proportions of PLWH aware of their infection, but low adherence to ART
(upper right corner), then ART homophily increases the impact of ART by close to 50% rela-
tive to similar contexts in which networks would be formed at random with respect to ART sta-
tus. On the other hand, if ART adherence is high, then the emergence of ART clusters can
reduce the expected impact of ART on HIV incidence. For example, in populations where a
limited proportion of PLWH are diagnosed,ART homophily may reduce the impact of ART
by close to 25% (lower left corner).
Discussion
Unlike other sexual mixing patterns such as serosorting [44, 45, 64, 65] and mixing between
and across subgroups with varying levels of sexual risk behaviour [4, 66], ART homophily has
not previously been considered in mathematical models of the effectiveness of ART for HIV
prevention. This is a significant gap since the ART status of potential partners can play a signif-
icant role in relationship decisions among ART patients [27].
Table 2. Hypotheses and projections for the main model scenarios (see also Fig 5).
Hypotheses Concentrated HIV epidemics Generalised HIV epidemics Hyperendemic HIV epidemics
HIV prevalence (h)  1%  10%  35%
Intra-couple ART
prevention
effectiveness (r)
Available evidence suggests that ART
confers a similar prevention benefit to
MSM as to heterosexual serodiscordant
couples
A systematic review and meta-analysis of
prospective studies among
serodiscordant couples suggests that
ART may reduce HIV incidence by 66% to
96%
A systematic review and meta-analysis of
prospective studies among serodiscordant
couples suggests that ART may reduce
HIV incidence by 66% to 96%
Fraction of PLWH
who know HIV status
(d)
In some concentrated HIV epidemics
(e.g. MSM in Switzerland), more than
75% of PLWH know their status, but in
other key populations (e.g. people who
inject drugs) in Asia, this fraction may be
far below 50%
About half of all PLWH in Sub-Saharan
Africa know their status, but knowledge of
HIV status is lower among youth and men.
About half of all PLWH in Sub-Saharan
Africa know their status, but knowledge of
HIV status is lower among youth and men.
Fraction of ART
patients among
diagnosed PLWH (a)
Estimates range from 40% in the USA to
77% in Australia
Close to 90% of PLWH who know their
status in sub-Saharan Africa are receiving
ART.
Close to 90% of PLWH who know their
status in sub-Saharan Africa are receiving
ART.
Level of HIV
serosorting (n)
Estimates for the prevalence of
serosorting among MSM range between
10% and 40%
There are currently no quantitative data
on the extent of serosorting in generalized
epidemics
There are currently no quantitative data on
the extent of serosorting in hyperendemic
epidemics
Projections
Effect of ART
clusters
ART clusters may enhance impact of
ART on HIV incidence by up to 50% if
intra-couple ART prevention
effectiveness is poor
ART clusters may enhance impact of ART
on HIV incidence by up to 50% if intra-
couple ART prevention effectiveness is
poor
ART clusters may reduce ART impact by
about 25% if intra-couple ART prevention
effectiveness is high
Effect of HIV
serosorting
HIV serosorting reduces the impact of
ART on HIV incidence, but does not
influence the relative effect of ART
clusters
HIV serosorting reduces the impact of
ART on HIV incidence, but does not
influence the relative effect of ART
clusters
HIV serosorting reduces the impact of ART
on HIV incidence, but does not influence
the relative effect of ART clusters
doi:10.1371/journal.pone.0163159.t002
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Using an exploratory mathematical model, we showed that ART homophily may modify
the prevention impact of ART in a complex manner, depending simultaneously on the perfor-
mance of HIV testing and treatment programmes (e.g., coverage of HIV testing and ART
adherence) and the epidemiological context (HIV prevalence). Our analysis further showed
how the effect of ART homophily is different from that of serosorting.
In concentrated epidemics and in generalized epidemics where HIV prevalence is no more
than 10%, ART homophily enhances the impact of ART on HIV incidence. On the other hand,
the impact of ART clusters may be more complex in hyperendemic settings where the HIV
prevalence among certain gender-age strata may reach or even exceed 35% [54–57]. In such
settings, ART homophily also enhances the impact of ART on HIV incidence when HIV status
awareness among PLWH (d), and therefore ART coverage (da) are high, and adherence to
ART is low. This is so because ART patients who do not adhere to treatment remain infective.
In that case, ART clusters provide indirect protection to HIV-negative individuals by limiting
their contact with potential sources of HIV transmission.
In contrast, in hyperendemic settings where HIV status awareness (and hence ART cover-
age) is low but adherence to ART is high, ART homophily may reduce the impact of ART on
population-level HIV incidence. In this scenario, highly-adherent ART patients (who are sig-
nificantly less infective than other PLWH) would have helped interrupt chains of HIV trans-
mission in sexual networks connected to HIV-negative individuals. Instead, because of ART
clusters, HIV-negative individuals are more likely to come into contact with undiagnosed (and
untreated) and thus more infective PLWH. Since the combination of high ART adherence and
low ART coverage characterizesmost current ART programmes in sub-Saharan countries,
ART may at the moment have a lower impact on HIV incidence than estimated by standard
mathematical models without ART homophily [67, 68].
Our model projections provide qualitative insight into why ART clusters may affect the
impact of ART on HIV incidence. Our goal was not, however, to make precise, quantitative
statements about the expected effects of ART clustering for specific populations or geographi-
cal regions. Accordingly, our analysis has several important limitations. Firstly, empirical
investigations of ART homophily (the value ofm) are required to obtain a quantitative under-
standing of the effect of ART homophily on the effectiveness of ART. Such data are not cur-
rently available, so we let our model span the entire range of possible parameters. Questions
about the ART status of one’s sexual partners should thus be included in studies of sexual
behaviours conducted among ART patients, as is already the case in the MaxART study, an
ongoing implementation study of early access to ART for all PLWH in Swaziland [69]. Sec-
ondly, our model only considered situations in which there was no risk compensation among
ART patients. Future investigations of ART homophily should incorporate interactions
between risk compensation and the emergence of ART clusters. Thirdly, we only considered
ART-related sexual mixing patterns. But partner choices could be more complex in the context
of combination prevention, in which ART is scaled-up alongside other HIV prevention inter-
ventions such as medical male circumcision. Fourthly, our model did not include the acute
phase of HIV infection, during which PLWH have an elevated viral load and are highly infec-
tious [70, 71]. Incorporating an acute phase with increased infectiousness and (near) zero cov-
erage of ART during this phase would change the model’s estimate for the impact of ART on
HIV incidence. However, given that ART coverage and ART clustering are likely extremely low
among people in the acute phase of HIV infection in both the base scenario and comparison
scenario, adding this phase to the model would not affect the relative impact of ART on HIV
incidence.We also only considered populations in which all individuals have the same number
of sexual partners, even though heterogeneity in sexual activity and other forms of sexual net-
work structure influence the impact of ART on HIV incidence [4]. It is less clear, however, if
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these network attributes also affect the relative effect of ART clusters on the HIV prevention
benefits of ART. Moreover, assortative mixing, by sexual activity level, age, or other demo-
graphic or behavioural attributes, may lead indirectly to apparent serosorting.While our
model assumes homogeneous sexual activity, it does allows for an arbitrary degree of serosort-
ing among HIV-positive individuals, without making specific assumptions about the underly-
ing dynamics that led to serosorting. Therefore, our model is not necessarily at odds with a
more complicated model in which heterogeneity in sexual activity and some degree of assorta-
tive mixing by sexual activity level leads to serosorting. Finally, we focused on exploring the
instantaneous change in the effectiveness of ART in reducing HIV incidence following the
emergence of ART homophily. In doing so, we did not fully characterise the dynamics of the
HIV transmission system we analysed, nor did we investigate its equilibriumproperties. Future
research on the impact of ART homophily should thus use more refinedmodelling strategies
including network models or compartmental models, which permit addressing these questions.
Conclusions
We show that ART homophily in sexual networks can significantlymodify the population-
level impact of ART on HIV incidence, even in the absence of risk compensation. But the mag-
nitude and the direction of this modification depends on many other variables: HIV preva-
lence, coverage of HIV testing and ART, ART adherence and the level of serosorting.Our
results suggest that the mathematical models that are being used to estimate the current and
future impact of TasP programmes should be amended to take into account the possible emer-
gence of ART clusters in sexual networks during the course of ART scale-up. This inclusion
would yield a better estimation of expected reductions in HIV incidence due to accelerated
access to ART, as well as a better understanding of observed time trends in HIV incidence after
ART scale-up. In contexts where ART clusters could enhance the impact of ART on HIV inci-
dence (e.g. low prevalence settings), measures to promote the formation of ART clusters (e.g.
by organising ART initiation and post-initiation follow-up for couples) could constitute useful
complementary interventions in combination HIV prevention programmes.
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